Department of Pediatric Nephrology, St Johns Medical College and Hospital, Bengaluru, India.
Department of Pediatric Intensive Care (PICU), St Johns Medical College and Hospital, Bengaluru, India.
Pediatr Crit Care Med. 2023 Mar 1;24(3):e121-e127. doi: 10.1097/PCC.0000000000003127. Epub 2023 Jan 23.
To evaluate use of sustained low efficiency dialysis (SLED) in critically ill children with acute kidney injury in a resource-limited setting.
Observational database cohort study (December 2016 to January 2020).
PICU of a tertiary hospital in India.
Critically ill children undergoing SLED were included in the study.
None.
Demographic and clinical data, prescription variables, hemodynamic status, complications, kidney, and patient outcomes of all children undergoing SLED in the PICU were analyzed. A total of 33 children received 103 sessions of SLED. The median (interquartile range, IQR) age and weight of children who received SLED were 9 years (4.5-12.8 yr) and 26 kg (15.2-34 kg), respectively. The most common diagnosis was sepsis with septic shock in 17 patients, and the mean (± sd ) Pediatric Risk of Mortality III score at admission was 11.8 (±6.4). The median (IQR) number and mean (± sd ) duration of inotropes per session were 3 hours (2-4 hr) and 96 (±82) hours, respectively. Of 103 sessions, the most common indication for SLED was oligoanuria with fluid overload and the need for creating space for fluid and nutritional support in 45 sessions (44%). The mean (± sd ) duration of SLED was 6.4 (±1.3) hours with 72 of 103 sessions requiring priming. The mean (± sd ) ultrafiltration rate per session achieved was 4.6 (±3) mL/kg/hr. There was significant decrease in urea and creatinine by end of SLED compared with the start, with mean change in urea and serum creatinine being 32.36 mg/dL (95% CI, 18.53-46.18 mg/dL) ( p < 0.001) and 0.70 mg/dL (95% CI, 0.35-1.06 mg/dL) ( p < 0.001), respectively. Complications were observed in 44 of 103 sessions, most common being intradialytic hypotension (21/103) and bleeding at the catheter site (21/103). Despite complications in one third of the sessions, only nine sessions were prematurely stopped, and 23 of 33 patients receiving SLED survived.
In critically ill children, our experience with SLED is that it is feasible and provides a viable form of kidney replacement therapy in a resource-limited setting.
在资源有限的情况下,评估持续低效透析(SLED)在患有急性肾损伤的危重症儿童中的应用。
观察性数据库队列研究(2016 年 12 月至 2020 年 1 月)。
印度一家三级医院的 PICU。
在 PICU 接受 SLED 的危重症儿童被纳入研究。
无。
分析了所有在 PICU 接受 SLED 的儿童的人口统计学和临床数据、处方变量、血流动力学状态、并发症、肾脏和患者结局。共有 33 名儿童接受了 103 次 SLED。接受 SLED 的儿童的中位(四分位距,IQR)年龄和体重分别为 9 岁(4.5-12.8 岁)和 26 公斤(15.2-34 公斤)。最常见的诊断是败血症合并败血症性休克,17 例患者的儿科死亡率 III 评分均值(±标准差)为 11.8(±6.4)。中位(IQR)每 session 使用的血管活性药物的数量和中位(IQR)持续时间分别为 3 小时(2-4 小时)和 96(±82)小时。在 103 次 SLED 中,最常见的适应症是少尿伴液体超负荷,需要创造空间以进行液体和营养支持,有 45 次(44%)符合这一条件。SLED 的中位(±标准差)持续时间为 6.4(±1.3)小时,其中 72 次需要预冲。每次 SLED 实现的平均超滤率为 4.6(±3)毫升/公斤/小时。与开始时相比,SLED 结束时尿素和肌酐明显下降,尿素和血清肌酐的平均变化分别为 32.36mg/dL(95%CI,18.53-46.18mg/dL)(p<0.001)和 0.70mg/dL(95%CI,0.35-1.06mg/dL)(p<0.001)。在 103 次 SLED 中,有 44 次出现并发症,最常见的是透析中低血压(21/103)和导管部位出血(21/103)。尽管三分之一的 session 出现并发症,但只有 9 次 session 提前停止,33 名接受 SLED 的患者中有 23 名存活。
在危重症儿童中,我们使用 SLED 的经验表明,在资源有限的情况下,SLED 是可行的,是一种可行的肾脏替代治疗方法。